Parkinson disease is a devastating neurodegenerative condition that is characterized by intraneuronal toxic assemblies of the α-synuclein protein. In this Comment, we discuss the emerging role of lipids in understanding biology as well as in the identification of new therapeutic targets in this disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The 3D structure of lipidic fibrils of α-synuclein
Nature Communications Open Access 10 November 2022
-
The docking of synaptic vesicles on the presynaptic membrane induced by α-synuclein is modulated by lipid composition
Nature Communications Open Access 10 February 2021
-
Neutral lipids as early biomarkers of cellular fate: the case of α-synuclein overexpression
Cell Death & Disease Open Access 07 January 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Shahmoradian, S. H. et al. Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 22, 1099–1109 (2019).
Theillet, F. X. et al. Structural disorder of monomeric α-synuclein persists in mammalian cells. Nature 530, 45–50 (2016).
Fusco, G. et al. Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour. Nat. Commun. 5, 3827 (2014).
Galvagnion, C. et al. Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein. Proc. Natl Acad. Sci. USA 113, 7065–7070 (2016).
Fusco, G. et al. Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers. Science 358, 1440–1443 (2017).
Zunke, F. et al. Reversible conformational conversion of α-synuclein into toxic assemblies by glucosylceramide. Neuron 97, 92–107 (2018).
Mazzulli, J. R. et al. Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146, 37–52 (2011).
Henderson, M. X. et al. Glucocerebrosidase activity modulates neuronal susceptibility to pathological α-synuclein insult. Neuron 105, 822–836 (2019).
Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat. Genet. 51, 414–430 (2019).
Fanning, S. et al. Lipidomic analysis of α-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment. Mol. Cell 73, 1001–1014 (2019).
Acknowledgements
We are grateful to the Azrieli Foundation for the award of an Azrieli Fellowship and Marguerite Stolz Research Fellowship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests
Rights and permissions
About this article
Cite this article
Stok, R., Ashkenazi, A. Lipids as the key to understanding α-synuclein behaviour in Parkinson disease. Nat Rev Mol Cell Biol 21, 357–358 (2020). https://doi.org/10.1038/s41580-020-0235-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41580-020-0235-y
This article is cited by
-
The 3D structure of lipidic fibrils of α-synuclein
Nature Communications (2022)
-
The docking of synaptic vesicles on the presynaptic membrane induced by α-synuclein is modulated by lipid composition
Nature Communications (2021)
-
Neutral lipids as early biomarkers of cellular fate: the case of α-synuclein overexpression
Cell Death & Disease (2021)